NIR‐II‐Excited Intravital Two‐Photon Microscopy Distinguishes Deep Cerebral and Tumor Vasculatures with an Ultrabright NIR‐I AIE Luminogen
Source abstract
Abstract
Abstract Intravital fluorescence imaging of vasculature morphology and dynamics in the brain and in tumors with large penetration depth and high signal‐to‐background ratio (SBR) is highly desirable for the study and theranostics of vascular‐related diseases and cancers. Herein, a highly bright fluorophore (BTPETQ) with long‐wavelength absorption and aggregation‐induced near‐infrared (NIR) emission (maximum at ≈700 nm) is designed for intravital two‐photon fluorescence (2PF) imaging of a mouse brain and tumor vasculatures under NIR‐II light (1200 nm) excitation. BTPETQ dots fabricated via nanoprecipitation show uniform size of around 42 nm and a high quantum yield of 19 ± 1% in aqueous media. The 2PF imaging of the mouse brain vasculatures labeled by BTPETQ dots reveals a 3D blood vessel network with an ultradeep depth of 924 µm. In addition, BTPETQ dots show enhanced 2PF in tumor vasculatures due to their unique leaky structures, which facilitates the differentiation of normal blood vessels from tumor vessels with high SBR in deep tumor tissues. Moreover, the extravasation and accumulation of BTPETQ dots in deep tumor (more than 900 µm) is visualized under NIR‐II excitation. This study highlights the importance of developing NIR‐II light excitable efficient NIR fluorophores for in vivo deep tissue and high contrast tumor imaging.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biomolecular Engineering National University of Singapore 4 Engineering Drive 4 Singapore 117585 Singapore
Institute of Advanced Materials (IAM) Nanjing Tech University 30 South Puzhu Road Nanjing 211800 China
Singapore Immunology Network (SIgN) Agency for Science, Technology and Research (A*STAR) 8A Biomedical Grove Singapore 138648 Singapore
Funding
National Research Foundation Singapore · National University of Singapore · National Natural Science Foundation of China
References (59)
Show source-provided references
1. 10.1038/nrc.2017.9310.1038/nrc.2017.93 ↗
2. 10.1038/nm.253710.1038/nm.2537 ↗
3. 10.1038/nrc162810.1038/nrc1628 ↗
4. 10.1038/nrclinonc.2011.2110.1038/nrclinonc.2011.21 ↗
5. 10.1126/science.110481910.1126/science.1104819 ↗
6. 10.1038/nnano.2012.4510.1038/nnano.2012.45 ↗
7. 10.1093/neuros/nyx32510.1093/neuros/nyx325 ↗
8. 10.1161/STROKEAHA.117.01981810.1161/STROKEAHA.117.019818 ↗
9. 10.1038/nm.272110.1038/nm.2721 ↗
10. 10.1002/adma.20110014010.1002/adma.201100140 ↗
11. 10.1002/adma.20170635610.1002/adma.201706356 ↗
12. Qi G. B. · Adv. Mater. · 2018 · 30 · 34
13. 10.1002/adma.20180222810.1002/adma.201802228 ↗
14. 10.1002/adfm.20170292810.1002/adfm.201702928 ↗
15. 10.1038/nrurol.2013.19610.1038/nrurol.2013.196 ↗
16. 10.1002/smll.20150073510.1002/smll.201500735 ↗
17. 10.1039/C7NR03086J10.1039/C7NR03086J ↗
18. 10.1002/adfm.20160384510.1002/adfm.201603845 ↗
19. 10.1016/j.addr.2016.05.02310.1016/j.addr.2016.05.023 ↗
20. 10.7150/thno.1630710.7150/thno.16307 ↗
21. 10.1038/nmeth81810.1038/nmeth818 ↗
22. 10.1002/adma.20160549710.1002/adma.201605497 ↗
23. 10.1038/s41551-016-001010.1038/s41551-016-0010 ↗
24. 10.1002/adma.20180239410.1002/adma.201802394 ↗
25. 10.1002/smll.20180554910.1002/smll.201805549 ↗
26. 10.2147/IJN.S19858710.2147/IJN.S198587 ↗
27. 10.1002/adfm.20180836510.1002/adfm.201808365 ↗
28. 10.1021/acsnano.8b0245210.1021/acsnano.8b02452 ↗
29. 10.1002/adhm.20170068510.1002/adhm.201700685 ↗
30. 10.1002/anie.20080525710.1002/anie.200805257 ↗
31. 10.1021/cr500442510.1021/cr5004425 ↗
32. 10.1039/C4CS00014E10.1039/C4CS00014E ↗
33. 10.1002/smll.20160087210.1002/smll.201600872 ↗
34. 10.1002/jso.2194310.1002/jso.21943 ↗
35. 10.1002/jso.2510510.1002/jso.25105 ↗
36. 10.1021/acsami.6b0590710.1021/acsami.6b05907 ↗
37. 10.1039/C6SC04384D10.1039/C6SC04384D ↗
38. 10.1016/j.cobme.2017.09.00410.1016/j.cobme.2017.09.004 ↗
39. 10.1021/acs.chemrev.5b0026310.1021/acs.chemrev.5b00263 ↗
40. 10.1021/acsnano.8b0839810.1021/acsnano.8b08398 ↗
41. 10.1002/adfm.20170694510.1002/adfm.201706945 ↗
42. 10.1002/adma.20170107610.1002/adma.201701076 ↗
43. 10.1002/adfm.20150001010.1002/adfm.201500010 ↗
44. 10.1002/adma.20130193810.1002/adma.201301938 ↗
45. 10.1021/acs.accounts.8b0006010.1021/acs.accounts.8b00060 ↗
46. 10.7150/thno.1039610.7150/thno.10396 ↗
47. 10.1364/BOE.6.00378310.1364/BOE.6.003783 ↗
48. 10.1039/C7SC04820C10.1039/C7SC04820C ↗
49. 10.1039/C8SC00633D10.1039/C8SC00633D ↗
50. 10.1021/acsnano.7b0564510.1021/acsnano.7b05645 ↗
51. 10.1038/nmat360810.1038/nmat3608 ↗
52. 10.1002/adma.20150014110.1002/adma.201500141 ↗
53. 10.1002/adma.20180522010.1002/adma.201805220 ↗
54. 10.1002/adom.20180003810.1002/adom.201800038 ↗
55. 10.1039/c3py01587d10.1039/c3py01587d ↗
56. 10.1039/C8TB00386F10.1039/C8TB00386F ↗
57. 10.1002/adfm.20130211410.1002/adfm.201302114 ↗
58. 10.1016/j.nbd.2009.07.03010.1016/j.nbd.2009.07.030 ↗
59. 10.1002/adfm.20190271710.1002/adfm.201902717 ↗